Etocarlide

Etocarlide

SCHEMBL2869798

CCCC[PH](CCCC)(CCCC)CCCC.CCOc1ccc(NC(=S)Nc2ccc(OCC)cc2)cc1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.73
GAA P10253 6/20 0.66
L3MBTL1 Q9Y468 1/20 0.59
PTGES O14684 1/20 0.58
ALDH1A1 P00352 6/20 0.56
KDM4E B2RXH2 2/20 0.56
LMNA P02545 5/20 0.55
KMT2A Q03164 5/20 0.53
MEN1 O00255 3/20 0.53
POLB P06746 2/20 0.53
HTT P42858 2/20 0.53
NSD2 O96028 1/20 0.53
HPGD P15428 1/20 0.53
BLM P54132 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MPI P34949 1/20 0.52
CYP1A2 P05177 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etocarlide SCHEMBL1652062 0.87 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL11050530 0.86 MAPT (0.93) MAPTGAAL3MBTL1PTGESALDH1A1
Etocarlide SCHEMBL9263 0.86 MAPT (1.00) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL103618 0.86 MAPT (1.00) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL11184352 0.84 MAPT (0.83) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL556369 0.84 MAPT (0.89) MAPTGAAL3MBTL1PTGESALDH1A1
Etocarlide SCHEMBL19741420 0.84 MAPT (0.89) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL250651 0.84 MAPT (0.89) MAPTGAAL3MBTL1PTGESALDH1A1
Etocarlide SCHEMBL21694441 0.84 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E
Etocarlide SCHEMBL522112 0.84 MAPT (0.96) MAPTGAAL3MBTL1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842843-B2 Mixture containing 1,3-butadiene and process for producing the same KURARAY CO., LTD. (JP) 2010-11-30 US disclosed
US-7728180-B2 Method for producing ethers KURARAY CO., LTD. (JP) 2010-06-01 US disclosed
US-20080262272-A1 Method For Producing Ethers KURARAY CO., LTD. (JP) 2008-10-23 US disclosed
EP-1795578-A2 Mixture containing 1, 3-Butadiene and process for producing the same Kuraray Co., Ltd. (JP) 2007-06-13 EP disclosed
US-20070123738-A1 MIXTURE CONTAINING 1,3-BUTADIENE AND PROCESS FOR PRODUCING THE SAME KURARAY CO., LTD (JP) 2007-05-31 US disclosed
EP-1760061-A1 METHOD FOR PRODUCING ETHERS KURARAY CO., LTD. (JP) 2007-03-07 EP disclosed
US-4399272-A COPOLYMERIZING FORMALDEHYDE AND AN ALKYLENE OXIDE OR CYCLIC FORMAL USING A LEWIS ACID AND ANIONIC CATALYST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1983-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123738-A1 MIXTURE CONTAINING 1,3-BUTADIENE AND PROCESS FOR PRODUCING THE SAME TELO2, MSMO1, HBG1 MAPT 1584/4885GAA 4417/4885L3MBTL1 1237/4885
US-20080262272-A1 Method For Producing Ethers TELO2, PDS5A, TERT MAPT 3987/4885GAA 4520/4885L3MBTL1 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.